Table 4.
Dashboards for the Required Training | Number of Respondents (n = 55) |
---|---|
Minimum/maximum dashboard | 38 (69.1%) |
Demand planning dashboard | 33 (60.0%) |
Integrated medicines availability dashboard | 33 (60.0%) |
Supplier management dashboard | 28 (50.9%) |
Integrated medicines availability dashboard—trend analysis | 26 (47.3%) |
Historic dashboards—primary healthcare level data only | 22 (40.0%) |
TEE/TLD transition dashboard | 20 (36.4%) |
COVID-19: vaccine dashboard | 16 (29.1%) |
Historic dashboards—hospital level data only | 14 (25.5%) |
COVID-19—supply chain | 12 (21.8%) |
COVID-19—PPE dashboard | 6 (10.9%) |
Pre-exposure prophylaxis | 2 (3.6%) |
Nota Bene: TEE/TLD: Tenofovir, Emtricitabine, Efavirenz/Tenofovir, Lamivudine, Dolutegravir; PPE: Personal Protective Equipment.